Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Bicalutamide
Drug ID BADD_D00271
Description Bicalutamide is an oral non-steroidal anti-androgen for prostate cancer. It is comprised of a racemic mixture that is a 50:50 composition of the (R)-bicalutamide and (S)-bicalutamide enantionmers. Bicalutamide binds to the androgen receptor.
Indications and Usage For treatment (together with surgery or LHRH analogue) of advanced prostatic cancer.
Marketing Status Prescription; Discontinued
ATC Code L02BB03
DrugBank ID DB01128
KEGG ID D00961
MeSH ID C053541
PubChem ID 2375
TTD Drug ID D0V9BD
NDC Product Code 60429-177; 70518-2993; 51846-1028; 16714-816; 62559-680; 0904-6019; 16729-023; 43265-0705; 15308-0360; 54893-0001; 49711-1504; 65841-613; 43265-7195; 49711-1509; 71205-577; 68382-224; 47335-485; 63629-8308; 63759-0004; 62559-890; 53104-7664; 46014-1111; 58623-0068
Synonyms bicalutamide | 4'-cyano-3-(4-fluorophenylsulfonyl)-2-hydroxy-2-methyl-3'-(trifluoromethyl)propionanilide | Casodex | Cosudex | ICI-176334 | ICI 176334
Chemical Information
Molecular Formula C18H14F4N2O4S
CAS Registry Number 90357-06-5
SMILES CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Rib fracture12.04.07.001; 15.08.07.0010.006444%Not Available
Scab23.03.03.0040.006444%Not Available
Sciatica17.10.03.001; 15.10.01.0010.012889%Not Available
Seizure17.12.03.001--
Sepsis11.01.11.0030.007565%
Sexual dysfunction19.08.05.002; 21.03.02.0030.006444%Not Available
Shock24.06.02.0020.009667%Not Available
Sinus bradycardia02.03.03.0090.006444%
Sinusitis11.01.13.005; 22.07.03.007--
Skin cancer23.08.02.002; 16.03.02.002--Not Available
Skin disorder23.03.03.0070.006444%Not Available
Skin hyperpigmentation23.05.01.0030.006444%
Skin hypertrophy23.01.04.002--Not Available
Skin ulcer23.07.03.003; 24.04.03.007--
Small intestinal obstruction07.13.06.0010.012889%
Somnolence19.02.05.003; 17.02.04.006--
Spinal compression fracture15.08.05.004; 14.04.04.003; 12.04.04.0010.006444%Not Available
Spinal cord compression17.10.01.0060.003362%
Spinal osteoarthritis15.01.04.0030.006444%Not Available
Squamous cell carcinoma16.16.01.0020.012889%Not Available
Stevens-Johnson syndrome10.01.03.020; 23.03.01.007; 12.03.01.014; 11.07.01.0050.009667%
Subdural haematoma24.07.04.005; 17.08.05.002; 12.01.10.0030.001681%Not Available
Sudden death08.04.01.003; 02.03.04.0130.005043%
Suicidal ideation19.12.01.003--
Suicide attempt19.12.01.004--
Supraventricular tachycardia02.03.03.0120.009667%
Swelling08.01.03.015--Not Available
Syncope24.06.02.012; 17.02.04.008; 02.01.02.0080.041889%
Systemic lupus erythematosus23.03.02.006; 15.06.02.003; 10.04.03.0040.012889%Not Available
Tachycardia02.03.02.0070.025778%Not Available
The 12th Page    First    Pre   12 13 14 15 16    Next   Last    Total 17 Pages